On the other hand, for those with cancer recurrence in the LV phase (N = 38, “Rec”), KRT17 expression was significantly elevated compared to not only the best threshold for UBC detection but also the expression level in the “No Rec” throughout the study period (p < 0.0001) (Fig. 4A). This evidence concerns the gene KRT17 and cancer.